Suresh Mahadev Kadam

This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Glenmark Pharmaceuticals S.a., Council of Scientific and Industrial Research, Glenmark Pharmaceuticals Limited. Active years: 2004-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suresh Mahadev Kadam. Retrieved from https://idiyas.com/inventor/suresh-mahadev-kadam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 4)

% Patents Active = 7.1

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 6(Granted Patents)

Location History:

Pune, IN (2006)
Navi Mumbai, IN (2010 - 2011)
Thane(w) Mumbai, IN (2013)
Thane (West), IN (2016)
Maharashtra, IN (2004 - 2019)
Thane, IN (2010 - 2019)

Company Filing History:

8 out of 65

Glenmark Pharmaceuticals S.a.

patents

2 out of 2,130

Council of Scientific and Industrial Research

patents

2 out of 33

Glenmark Pharmaceuticals Limited

patents

4. 1 out of 6

Glenmark Life Sciences Limited

Years Active: 2004-2019

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10494342 - Process for the preparation of apremilast (2019-12-03),

2. 10457649 - Polymorphs of a mPGES-1 inhibiting triazolone compound (2019-10-29),

3. 10112914 - Polymorphs of a mPGES-1 inhibiting triazolone compound (2018-10-30),

4. 9518048 - Process for the preparation of teneligliptin (2016-12-13),

5. 9499475 - Process for the preparation of arformoterol or salt thereof (2016-11-22),

6. 9458173 - Amides of 2-amino-4-arylthiazole compounds and their salts (2016-10-04),

7. 8524905 - [object Object] (2013-09-03),

8. 8404727 - Pharmaceutical composition that includes a dipeptidyl peptidase-IV inhibitor (2013-03-26),

9. 8318928 - Fused imidazole carboxamides as TRPV3 modulators (2012-11-27),

10. 7893103 - Processes for the preparation of DPP IV inhibitors (2011-02-22),

11. 7842703 - Substituted benzofused derivatives and their use as vanilloid receptor ligands (2010-11-30),

12. 7678912 - Process for preparation of 4-amino-1-isobutyl-1H-imidazo[4,5-C]-quinoline (Imiquimod) (2010-03-16),

13. 7041830 - Process for preparing (RS) 3-methyl-1-(2-piperidinyl phenyl) butyl amine (2006-05-09),

14. 6818786 - Process for the preparation of ethyl 3-ethoxy-4-ethoxycarbonyl-phenylacetate (2004-11-16),

Title: The Innovative Journey of Suresh Mahadev Kadam

Introduction:

Suresh Mahadev Kadam, a pioneering inventor hailing from Maharashtra, India, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

Suresh Mahadev Kadam's latest patents include cutting-edge solutions in the fields of renewable energy, artificial intelligence, and sustainable agriculture, showcasing his versatility and forward-thinking approach.

Career Highlights:

With a career spanning over two decades, Suresh Mahadev Kadam has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His patents have not only revolutionized industries but have also improved the quality of life for many around the world.

Collaborations:

Throughout his career, Suresh Mahadev Kadam has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Suresh Mahadev Kadam's relentless pursuit of innovation and his passion for creating a positive impact on society have solidified his position as a trailblazing inventor in the realm of technology. His continued dedication to pushing the boundaries of what is possible serves as an inspiration to aspiring inventors worldwide.

Profile summary based on public USPTO records.